[Leish-l] LEISHMANIASIS, CUTANEOUS - LIBYA: (AL MARQAB)

Wed Apr 18 19:22:00 BRT 2018

 LEISHMANIASIS, CUTANEOUS - LIBYA: (AL MARQAB)
*********************************************
A ProMED-mail post
<http://www.promedmail.org
<https://eur02.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.promedmail.org&data=02%7C01%7C%7C14113c78726f4ac7b1b908d5a241dc43%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C636593326105936851&sdata=lWRK4NegHH9lsXQwewWYMtMxIsZ8bGcnYdvLYWO4K00%3D&reserved=0>
>
ProMED-mail is a program of the
International Society for Infectious Diseases
<http://www.isid.org
<https://eur02.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.isid.org&data=02%7C01%7C%7C14113c78726f4ac7b1b908d5a241dc43%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C636593326105936851&sdata=hABhvYjcvp%2BNyd26sllXuf5L7Gt2O4dVZJJ2VHMt%2BnE%3D&reserved=0>
>

Date: Tue 10 Apr 2018, 3:19 PM
Source: Libya Observer [edited]
<https://www.libyaobserver.ly/health/leishmaniasis-warning-i
ssued-libya%E2%80%99s-zliten
<https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.libyaobserver.ly%2Fhealth%2Fleishmaniasis-warning-issued-libya%25E2%2580%2599s-zliten&data=02%7C01%7C%7C14113c78726f4ac7b1b908d5a241dc43%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C636593326105936851&sdata=D6hHoeBN63jTZbkAvoFCMeeev9quy7Tx96JiSOMO6fA%3D&reserved=0>
>

The Director of the Environmental Health Office in Zliten, Mohammed
Abu Qamiza, confirmed on [Mon 9 Apr 2018] that the recorded cases of
leishmaniasis this year [2018] has increased to 51 persons in the city
[Zliten].

In a press statement, Abu Qamiza explained that there is no cure at
the current time for the disease in Libya, noting that the cost of
treatment for this disease is prohibitively expensive and could amount
to 10 000 Libyan dinars per person [approx. 7547 USD].

He called on the Ministry of Health and the National Centre for
Communicable Diseases to take the necessary action in order to contain
the disease.

Earlier this month [April 2018], Zliten Municipality warned against
the spread of leishmaniasis, declaring that 351 cases were recorded in
the city in 2017.

Mayor Miftah Hammadi urged the government health officials in to
contract a specialized company to combat the disease ahead of summer.

Leishmaniasis is a parasitic disease spread to humans by bites of
sandflies that are usually active from May to September each year.

[Byline: Safa Alharathy]

--
Communicated by:
ProMED-mail from HealthMap Alerts
<promed at promedmail.org>

[Zliten is a town in Murqub [Al Murqub or Al Marqab] District on the
Mediterranean cost approximately 175 km (109 miles) east of Tripoli.
We assume that the cases are cutaneous leishmaniasis.

A recent study mapping of cutaneous leishmaniasis in Libya concluded:
"Future projection of CL until 2060 showed a trend of increasing
incidence of CL in the north-western part of Libya, a spread along the
coastal region and a possible emergence of new endemics in the
north-eastern districts of Libya. These results should be considered
for control programs to prevent the emergence of new endemic areas
taking also into consideration changes in socio-economical factors
such as migration, conflicts, urbanization, land use and access to
health care" (Amro A, Al-Dwibe H, Gashout A et al. Spatiotemporal and
molecular epidemiology of cutaneous leishmaniasis in Libya. PLoS Negl
Trop Dis. 2017;11(9):e0005873; available at
<https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5605087/
<https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5605087%2F&data=02%7C01%7C%7C14113c78726f4ac7b1b908d5a241dc43%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C636593326105936851&sdata=lF6a9f0jm15np3MURMTvkSEzZplYG2BDjXvJw%2FUk7hY%3D&reserved=0>>).
- Mod.EP

HealthMap/ProMED-mail map:
Al Murqub District, Libya: <http://healthmap.org/promed/p/27185
<https://eur02.safelinks.protection.outlook.com/?url=http%3A%2F%2Fhealthmap.org%2Fpromed%2Fp%2F27185&data=02%7C01%7C%7C14113c78726f4ac7b1b908d5a241dc43%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C636593326105936851&sdata=UcVilPFyZLCViqA7uYpIAR4RyQnM0tDICvOpFSkhkew%3D&reserved=0>
>]

[See Also:
2016
----
Leishmaniasis, cutaneous - Libya: (TR):
http://promedmail.org/post/20160414.4160311
<https://eur02.safelinks.protection.outlook.com/?url=http%3A%2F%2Fpromedmail.org%2Fpost%2F20160414.4160311&data=02%7C01%7C%7C14113c78726f4ac7b1b908d5a241dc43%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C636593326105936851&sdata=sVOuEk5YQKRc%2FT4Eu5LO0fuJ15%2FkI1namj9GI8bd%2BOg%3D&reserved=0>
2015
----
Leishmaniasis, cutaneous - Libya: (TR)
http://promedmail.org/post/20151012.3710620
<https://eur02.safelinks.protection.outlook.com/?url=http%3A%2F%2Fpromedmail.org%2Fpost%2F20151012.3710620&data=02%7C01%7C%7C14113c78726f4ac7b1b908d5a241dc43%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C636593326105936851&sdata=m5MVfEc2oJHHjjDfjRolzeVNsB4tU8W9zXh9%2BSo6Ppk%3D&reserved=0>
]
.................................................sb/ep/ao/jh
*##########################################################*
************************************************************
ProMED-mail makes every effort to  verify  the reports  that
are  posted,  but  the  accuracy  and  completeness  of  the
information,   and  of  any  statements  or  opinions  based
thereon, are not guaranteed. The reader assumes all risks in
using information posted or archived by  ProMED-mail.   ISID
and  its  associated  service  providers  shall not be  held
responsible for errors or omissions or  held liable for  any
damages incurred as a result of use or reliance upon  posted
or archived material.
************************************************************
Donate to ProMED-mail. Details available at:
<http://www.isid.org/donate/
<https://eur02.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.isid.org%2Fdonate%2F&data=02%7C01%7C%7C14113c78726f4ac7b1b908d5a241dc43%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C636593326105936851&sdata=7xzMpzjf12wP%2Fv%2FabryV0Pg%2FaPTQXk42KNxeMCYN6FU%3D&reserved=0>
>
************************************************************
Visit ProMED-mail's web site at <http://www.promedmail.org
<https://eur02.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.promedmail.org&data=02%7C01%7C%7C14113c78726f4ac7b1b908d5a241dc43%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C636593326105936851&sdata=lWRK4NegHH9lsXQwewWYMtMxIsZ8bGcnYdvLYWO4K00%3D&reserved=0>
>.
Send all items for posting to: promed at promedmail.org (NOT to
an individual moderator).  If you do not give your full name
name and affiliation,  it may not be posted.  You may unsub-
scribe at  <http://ww4.isid.org/promedmail/subscribe.php
<https://eur02.safelinks.protection.outlook.com/?url=http%3A%2F%2Fww4.isid.org%2Fpromedmail%2Fsubscribe.php&data=02%7C01%7C%7C14113c78726f4ac7b1b908d5a241dc43%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C636593326105936851&sdata=f%2FzgcqCm126wo7qBkX5VQpoJ7gX14aDiJAVyIMwP5Hg%3D&reserved=0>
>.
For  assistance  from   a   human   being, send mail to:
<postmaster at promedmail.org>.
############################################################
############################################################